Phase
Condition
Lymphoma
Neutropenia
Treatment
N/AClinical Study ID
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Adult patients (age 18 years or above)
Refractory or relapsed aggressive lymphoma, including Hodgkin's and non-Hodgkin'slymphoma
Candidate for salvage chemotherapy. Salvage chemotherapy includes one of the followingregimens: Ifosfamide, etoposide, vincristine (ICE), Cisplatin, cytarabine, anddexamethasone (DHAP), Etoposide, methylprednisolone, cytarabine, cisplatin (ESHAP).Chemotherapy dose reduction will be allowed.
Chemotherapy with or without immunotherapy
Therapy in hospital or at the outpatient clinic
Exclusion
Exclusion Criteria:
Indolent lymphoma; we will exclude patients with transformed lymphoma.
Treatment with GCSFs for the primary disease (e.g. aplastic anemia, MDS).
Uncontrolled infection
Pregnant women
Study Design
Connect with a study center
Rabin Medical Center
Petah Tikva, 49100
IsraelSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.